Request for Covid-19 Impact Assessment of this Report
The global Cystic Fibrosis Drugs market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Oral
Injection
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Actavis
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
Novo Nordisk
PharmaSwiss
Pharmaxis
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Oral
1.2.1.2 Injection
1.2.2 by Application
1.2.2.1 Hospitals
1.2.2.2 Clinics
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Oral Market, 2013-2018
4.1.2 Injection Market, 2013-2018
4.2 Market Forecast
4.2.1 Oral Market Forecast, 2019-2023
4.2.2 Injection Market Forecast, 2019-2023
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospitals Market, 2013-2018
5.1.2 Clinics Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospitals Market Forecast, 2019-2023
5.2.2 Clinics Market Forecast, 2019-2023
5.2.3 Others Market Forecast, 2019-2023
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Actavis
8.2 F. Hoffmann-La Roche
8.3 Gilead Sciences
8.4 Novartis
8.5 Vertex Pharmaceuticals
8.6 Abbott
8.7 Anthera Pharmaceuticals
8.8 Arcturus Therapeutics
8.9 Boehringer Ingelheim
8.10 Chiesi Farmaceutici
8.11 Corbus Pharmaceuticals
8.12 Genzyme
8.13 Insmed
8.14 Johnson & Johnson
8.15 Merck Sharp & Dohme
8.16 Neovii Biotech
8.17 Novo Nordisk
8.18 PharmaSwiss
8.19 Pharmaxis
8.20 Proteostasis Therapeutics
8.21 PTC Therapeutics
8.22 United Medical
8.23 Venus Remedies
9 Conclusion
Table Product Specifications of Cystic Fibrosis Drugs
Table Products Segment of Cystic Fibrosis Drugs
Table Oral Overview
Table Injection Overview
Table Global Cystic Fibrosis Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Cystic Fibrosis Drugs
Table Hospitals Overview
Table Clinics Overview
Table Others Overview
Table Global Cystic Fibrosis Drugs Market by Application, 2011-2022 (USD Million)
Table Global Cystic Fibrosis Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Cystic Fibrosis Drugs
Table Market Dynamics
Table Policy of Cystic Fibrosis Drugs
Table GDP of Major Countries
Table Oral CAGR by Revenue and Volume, 2012-2018
Table Injection CAGR by Revenue and Volume, 2012-2018
Table Oral CAGR by Revenue and Volume, 2012-2022
Table Injection CAGR by Revenue and Volume, 2012-2022
Table Hospitals CAGR by Revenue and Volume, 2012-2018
Table Clinics CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Cystic Fibrosis Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Cystic Fibrosis Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Cystic Fibrosis Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Cystic Fibrosis Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Actavis Profile List
Table Microecological Modulator Operating Data of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vertex Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Vertex Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Profile List
Table Microecological Modulator Operating Data of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Anthera Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Anthera Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arcturus Therapeutics Profile List
Table Microecological Modulator Operating Data of Arcturus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Chiesi Farmaceutici Profile List
Table Microecological Modulator Operating Data of Chiesi Farmaceutici (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Corbus Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Corbus Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genzyme Profile List
Table Microecological Modulator Operating Data of Genzyme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Insmed Profile List
Table Microecological Modulator Operating Data of Insmed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Sharp & Dohme Profile List
Table Microecological Modulator Operating Data of Merck Sharp & Dohme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Neovii Biotech Profile List
Table Microecological Modulator Operating Data of Neovii Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PharmaSwiss Profile List
Table Microecological Modulator Operating Data of PharmaSwiss (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmaxis Profile List
Table Microecological Modulator Operating Data of Pharmaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Proteostasis Therapeutics Profile List
Table Microecological Modulator Operating Data of Proteostasis Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PTC Therapeutics Profile List
Table Microecological Modulator Operating Data of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Medical Profile List
Table Microecological Modulator Operating Data of United Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Venus Remedies Profile List
Table Microecological Modulator Operating Data of Venus Remedies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...